Bank of New York Mellon Corp - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 81 filers reported holding IMMUNOMEDICS INC in Q4 2013. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$78,052,000
+164.1%
917,939
+10.1%
0.02%
+137.5%
Q2 2020$29,557,000
+151.1%
833,984
-4.5%
0.01%
+100.0%
Q1 2020$11,770,000
-34.7%
873,148
+2.6%
0.00%
-20.0%
Q4 2019$18,011,000
+63.5%
851,108
+2.5%
0.01%
+66.7%
Q3 2019$11,013,000
-5.9%
830,520
-1.5%
0.00%0.0%
Q2 2019$11,699,000
-17.9%
843,554
+13.7%
0.00%
-25.0%
Q1 2019$14,255,000
+42.3%
742,020
+5.7%
0.00%
+33.3%
Q4 2018$10,021,000
-31.6%
702,209
-0.1%
0.00%
-25.0%
Q3 2018$14,643,000
-12.3%
702,956
-0.4%
0.00%
-20.0%
Q2 2018$16,705,000
+90.3%
705,730
+17.4%
0.01%
+150.0%
Q1 2018$8,780,000
-5.9%
600,988
+4.1%
0.00%0.0%
Q4 2017$9,332,000
-2.0%
577,459
-15.3%
0.00%
-33.3%
Q3 2017$9,527,000
+71.8%
681,419
+8.5%
0.00%
+50.0%
Q2 2017$5,546,000
+84.7%
628,135
+35.3%
0.00%
+100.0%
Q1 2017$3,003,000
+85.7%
464,215
+5.3%
0.00%
Q4 2016$1,617,000
+21.8%
440,697
+7.8%
0.00%
Q3 2016$1,328,000
+32.7%
408,664
-5.3%
0.00%
Q2 2016$1,001,000
-4.9%
431,506
+2.4%
0.00%
Q1 2016$1,053,000
-23.0%
421,401
-5.4%
0.00%
Q4 2015$1,368,000
+85.1%
445,497
+3.8%
0.00%
Q3 2015$739,000
-67.6%
429,299
-23.6%
0.00%
-100.0%
Q2 2015$2,281,000
+13.0%
561,875
+6.6%
0.00%0.0%
Q1 2015$2,018,000
-5.9%
526,857
+17.9%
0.00%0.0%
Q4 2014$2,145,000
+34.2%
446,810
+4.0%
0.00%
Q3 2014$1,598,000
-43.4%
429,618
-44.5%
0.00%
Q2 2014$2,824,000
+80.8%
773,570
+108.4%
0.00%
Q1 2014$1,562,000
-9.0%
371,157
-0.5%
0.00%
Q4 2013$1,716,000
-64.3%
372,915
-51.9%
0.00%
-100.0%
Q3 2013$4,806,000
+124.0%
775,460
+96.5%
0.00%0.0%
Q2 2013$2,146,000394,6140.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
RP Management, LLC 4,373,178$371,851,00055.73%
Avoro Capital Advisors LLC 26,250,000$2,232,038,00031.71%
Twin Securities, Inc. 467,761$39,774,00028.60%
Palo Alto Investors LP 4,852,383$412,598,00022.65%
Sand Grove Capital Management LLP 470,000$39,964,00021.19%
Beryl Capital Management LLC 1,046,632$88,995,00016.02%
Western Standard LLC 158,065$13,440,00015.26%
One68 Global Capital, LLC 60,990$5,186,00013.76%
First Light Asset Management, LLC 1,577,880$134,167,00013.75%
Boxer Capital, LLC 4,500,000$382,635,00013.22%
View complete list of IMMUNOMEDICS INC shareholders